Human epidermal growth factor receptor 2 (HER2)-positive breast cancer constitutes a distinct subtype characterized by overexpression of the HER2 protein, affecting approximately 20–25% of breast cancer cases and associated with decreased survival [2]. Here, ERBB2 is linked to breast carcinoma.